Lifecore Biomedical, Inc. (LFCR)
NASDAQ: LFCR · Real-Time Price · USD
5.57
-0.06 (-1.07%)
At close: Jun 8, 2026, 4:00 PM EDT
5.50
-0.07 (-1.26%)
Pre-market: Jun 9, 2026, 5:10 AM EDT
Lifecore Biomedical Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | May '25 May 25, 2025 | May '24 May 26, 2024 | May '23 May 28, 2023 | May '22 May 29, 2022 |
Cash & Equivalents | 20.8 | 17.47 | 8.27 | 8.46 | 19.09 | 0.99 |
Cash & Short-Term Investments | 20.8 | 17.47 | 8.27 | 8.46 | 19.09 | 0.99 |
Cash Growth | 283.88% | 111.36% | -2.33% | -55.67% | 1826.44% | -14.49% |
Accounts Receivable | 19.44 | 26.16 | 28.69 | 27.08 | 29.02 | 38.31 |
Other Receivables | 7.45 | 7.66 | 14.98 | 4.07 | - | - |
Total Trade Receivables | 26.89 | 33.82 | 43.67 | 31.15 | 29.02 | 38.31 |
Inventory | 28.16 | 29.09 | 32.29 | 39.98 | 40.84 | 36 |
Other Current Assets | 1.8 | 1.92 | 1.45 | 1.44 | 4.92 | 41.36 |
Total Current Assets | 77.64 | 82.29 | 85.68 | 81.03 | 93.88 | 116.67 |
Net Property, Plant & Equipment | 125.51 | 127.3 | 129.01 | 149.17 | 138.67 | 124.22 |
Other Intangible Assets | - | - | 4.2 | 4.2 | 4.2 | 4.2 |
Goodwill | 13.88 | 13.88 | 13.88 | 13.88 | 13.88 | 13.88 |
Other Long-Term Assets | 8.47 | 8.7 | 6.58 | 5.68 | 2.92 | 15.73 |
Total Assets | 225.5 | 232.18 | 239.34 | 253.96 | 253.55 | 274.7 |
Accounts Payable | 7.01 | 6.21 | 8.22 | 16.33 | 22.1 | 12.95 |
Accrued Expenses | 13.48 | 17.36 | 21.96 | 22.54 | 11.29 | 15.42 |
Short-Term Debt | - | - | - | - | - | 40 |
Current Portion of Long-Term Debt | - | - | - | - | 0.58 | 98.18 |
Current Portion of Leases | - | - | - | - | 1.27 | 4.37 |
Unearned Revenue | - | - | - | - | 4.06 | 0.92 |
Other Current Liabilities | - | - | - | - | - | 4.74 |
Total Current Liabilities | 20.5 | 23.57 | 30.18 | 38.87 | 39.29 | 176.58 |
Long-Term Debt | 147.78 | 141.28 | 127 | 123.73 | 101.07 | - |
Long-Term Leases | - | - | - | - | 9.71 | 7.66 |
Other Long-Term Liabilities | 36.45 | 33.26 | 34.73 | 37.46 | 68.39 | 2.64 |
Total Long-Term Liabilities | 184.22 | 174.54 | 161.73 | 161.19 | 179.17 | 10.3 |
Total Liabilities | 204.72 | 198.12 | 191.91 | 200.06 | 218.46 | 186.88 |
Common Stock | 0.04 | 0.04 | 0.04 | 0.03 | 0.03 | 0.03 |
Additional Paid-in Capital | 209.71 | 208.96 | 206.54 | 177.81 | 174.28 | 167.35 |
Accumulated Other Comprehensive Income | - | - | - | - | - | -0.59 |
Retained Earnings | -238.18 | -223.2 | -205.24 | -166.52 | -178.54 | -78.97 |
Minority Interest | 49.22 | 48.26 | 46.1 | 42.59 | 39.32 | - |
Shareholders' Equity | -28.44 | -14.2 | 1.34 | 11.32 | -4.23 | 87.82 |
Total Liabilities & Equity | 225.5 | 232.18 | 239.34 | 253.96 | 253.55 | 274.7 |
Total Debt | 147.78 | 141.28 | 127 | 123.73 | 112.62 | 150.2 |
Net Cash (Debt) | -126.98 | -123.81 | -118.73 | -115.26 | -93.53 | -149.21 |
Net Cash Per Share | -3.40 | -3.30 | -3.41 | -3.14 | -3.12 | -5.06 |
Book Value | -28.44 | -14.2 | 1.34 | 11.32 | -4.23 | 87.82 |
Book Value Per Share | -0.76 | -0.38 | 0.04 | 0.31 | -0.14 | 2.98 |
Tangible Book Value | -42.32 | -28.08 | -16.75 | -6.77 | -22.31 | 69.74 |
Tangible Book Value Per Share | -1.13 | -0.75 | -0.48 | -0.18 | -0.74 | 2.37 |